Last updated on July 2019

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects 1 Month to <4 Years With Partial-onset Seizures


Brief description of study

The purpose of this trial is to assess the efficacy, safety and tolerabilty of lacosamide administered as add-on therapy with 1 to 3 anti-seizure medications. This trial is for children aged 1 month to less than 4 years with epilepsy who currently have uncontrolled partial-onset seizures.

Detailed Study Description

The trial consists of a 7-day Baseline Period, a 20-day Titration Period, a 7-day Maintenance Period, and a 12-day Transition Period for subjects who complete the study and choose to enter the extension study. Subjects who will not enter the extension study will continue after the Maintenance Period with a 16-day Taper Period followed by a 30-day Safety Follow-Up Period. The Taper Period and Safety Follow-Up are also applicable for subjects not eligible for continuation and therefore ending the study earlier.

If subjects meet the eligibility criteria, they will be randomized to receive either lacosamide 8 mg/kg/day to 12 mg/kg/day, or placebo during the Maintenance Phase. The dose of lacosamide will be titrated from 4 mg/kg/day at study start to maximum of 12 mg/kg/day at 4-day intervals of 1-2 mg/kg/day.

All subjects who complete the 20-day Titration Period will enter the 7-day Maintenance Period. No dose adjustment is allowed during the Maintenance Phase. The Treatment Phase is defined as the combined Titration and Maintenance Phases.

Clinical Study Identifier: NCT02477839

Find a site near you

Start Over

Sp0967 638

Birmingham, AL United States
  Connect »

Sp0967 135

Mobile, AL United States
  Connect »

Sp0967 105

Orlando, FL United States
  Connect »

Sp0967 117

Tampa, FL United States
  Connect »

Sp0967 641

Atlanta, GA United States
  Connect »

Sp0967 138

Saint Paul, MN United States
  Connect »

Sp0967 115

Henderson, NV United States
  Connect »

Sp0967 120

Lebanon, NH United States
  Connect »

Sp0967 636

Morristown, NJ United States
  Connect »

Sp0967 631

Poughkeepsie, NY United States
  Connect »

Sp0967 132

Cleveland, OH United States
  Connect »

Sp0967 129

Dallas, TX United States
  Connect »

Sp0967 630

San Antonio, TX United States
  Connect »

Sp0967 114

Seattle, WA United States
  Connect »

Sp0967 143

Buenos Aires, Argentina
  Connect »

Sp0967 206

Clayton, Australia
  Connect »

Sp0967 203

Parkville, Australia
  Connect »

Sp0967 201

Perth, Australia
  Connect »

Sp0967 202

Randwick, Australia
  Connect »

Sp0967 205

South Brisbane, Australia
  Connect »

Sp0967 158

Passo Fundo, Brazil
  Connect »

Sp0967 152

Porto Alegre, Brazil
  Connect »

Sp0967 310

Plovdiv, Bulgaria
  Connect »

Sp0967 312

Sofia, Bulgaria
  Connect »

Sp0967 522

Santiago, Chile
  Connect »

Sp0967 170

Cali, Colombia
  Connect »

Sp0967 613

Osijek, Croatia
  Connect »

Sp0967 610

Rijeka, Croatia
  Connect »

Sp0967 612

Zagreb, Croatia
  Connect »

Sp0967 342

Amiens, France
  Connect »

Sp0967 346

Rennes, France
  Connect »

Sp0967 344

Strasbourg, France
  Connect »

Sp0967 357

Bielefeld, Germany
  Connect »

Sp0967 355

Erlangen, Germany
  Connect »

Sp0967 351

Freiburg, Germany
  Connect »

Sp0967 353

Radeberg, Germany
  Connect »

Sp0967 541

Athens, Greece
  Connect »

Sp0967 542

Athens, Greece
  Connect »

Sp0967 361

Budapest, Hungary
  Connect »

Sp0967 362

Budapest, Hungary
  Connect »

Sp0967 363

Budapest, Hungary
  Connect »

Sp0967 364

Budapest, Hungary
  Connect »

Sp0967 360

Debrecen, Hungary
  Connect »

Sp0967 373

Zerifin, Israel
  Connect »

Sp0967 384

Bologna, Italy
  Connect »

Sp0967 385

Bologna, Italy
  Connect »

Sp0967 399

Calambrone, Italy
  Connect »

Sp0967 398

Messina, Italy
  Connect »

Sp0967 391

Salerno, Italy
  Connect »

Sp0967 214

Cheongju, Korea, Republic of
  Connect »

Sp0967 210

Seoul, Korea, Republic of
  Connect »

Sp0967 213

Seoul, Korea, Republic of
  Connect »

Sp0967 215

Seoul, Korea, Republic of
  Connect »

Sp0967 411

Kaunas, Lithuania
  Connect »

Sp0967 694

Aguascalientes, Mexico
  Connect »

Sp0967 561

Chihuahua, Mexico
  Connect »

Sp0967 563

Guadalajara, Mexico
  Connect »

Sp0967 568

Monterrey, Mexico
  Connect »

Sp0967 692

Monterrey, Mexico
  Connect »

Sp0967 696

Oaxaca de Juarez, Mexico
  Connect »

Sp0967 650

Chisinau, Moldova, Republic of
  Connect »

Sp0967 579

Bucuresti, Romania
  Connect »

Sp0967 573

Sibiu, Romania
  Connect »

Sp0967 464

Belgrade, Serbia
  Connect »

Sp0967 460

Kragujevac, Serbia
  Connect »

Sp0967 463

Novi Sad, Serbia
  Connect »

Sp0967 222

Taichung, Taiwan
  Connect »

Sp0967 224

Taipei, Taiwan
  Connect »

Sp0967 237

Bangkok, Thailand
  Connect »

Sp0967 682

Uzhgorod, Ukraine
  Connect »

Sp0967 604

Zaporizhzhya, Ukraine
  Connect »

Sp0967 680

Zaporizhzhya, Ukraine
  Connect »

Sp0967 535

Changchun, China
  Connect »

Sp0967 621

Tbilisi, Georgia
  Connect »

Sp0967 602

Dnipropetrovs'k, Ukraine
  Connect »

Sp0967 121

Shreveport, LA United States
  Connect »

Sp0967 531

Shanghai, China
  Connect »

Sp0967 620

Tbilisi, Georgia
  Connect »

Sp0967 622

Tbilisi, Georgia
  Connect »

Sp0967 623

Tbilisi, Georgia
  Connect »

Sp0967 374

Petah tikva, Israel
  Connect »

Sp0967 216

Seoul, Korea, Republic of
  Connect »

Sp0967 642

Cincinnati, OH United States
  Connect »

Sp0967 532

Chongqing, China
  Connect »

Sp0967 320

Ostrava-Poruba, Czechia
  Connect »

Sp0967 356

Berlin, Germany
  Connect »

Sp0967 352

Tuebingen, Germany
  Connect »

Sp0967 212

Seoul, Korea, Republic of
  Connect »

Sp0967 536

Nanchang, China
  Connect »

Sp0967 537

Shenzhen, China
  Connect »

Sp0967 534

Hangzhou, China
  Connect »

Sp0967 369

Balassagyarmat, Hungary
  Connect »

Sp0967 10508

Gyeonggi-do, Korea, Republic of
  Connect »

Sp0967 10021

San Antonio, TX United States
  Connect »

Sp0967 16323

Budapest, Hungary
  Connect »

Sp0967 643

San Antonio, TX United States
  Connect »

Sp0967 368

Budapest, Hungary
  Connect »

Sp0967 145

Bahía Blanca, Argentina
  Connect »

Sp0967 142

Córdoba, Argentina
  Connect »

Sp0967 149

Córdoba, Argentina
  Connect »

Sp0967 155

Niterói, Brazil
  Connect »

Sp0967 150

São Paulo, Brazil
  Connect »

Sp0967 154

São Paulo, Brazil
  Connect »

Sp0967 156

São Paulo, Brazil
  Connect »

Sp0967 177

Bogotá, Colombia
  Connect »

Sp0967 171

Medellín, Colombia
  Connect »

Sp0967 540

Thessaloníki, Greece
  Connect »

Sp0967 366

Pécs, Hungary
  Connect »

Sp0967 10691

Culiacán, Mexico
  Connect »

Sp0967 569

Culiacán, Mexico
  Connect »

Sp0967 693

Culiacán, Mexico
  Connect »

Sp0967 564

Delegación Tlalpan, Mexico
  Connect »

Sp0967 422

Kraków, Poland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.